Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in CELLDEX THERAPEUTICS INC NEW
WELLINGTON MANAGEMENT GROUP LLP holds 8.6M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $271.5M as of 2026-Q1. The position was increased (+6.0% shares). CLDX represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.
Current Value
$271.5M
Current Shares
8.6M
Total Value Change
-$27.4M
Total Shares Change
+484,536
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 8.6M |
+6.0% |
| $271.5M |
| 0.1% |
| $28.94 |
33 |
| 2025-Q4 | Increased | 8.1M | +39.3% | $219.4M | 0.0% | $26.43 | 40 |
| 2025-Q3 | Increased | 5.8M | +10.8% | $150M | 0.0% | $26.19 | 34 |
| 2025-Q2 | Decreased | 5.2M | -37.4% | $106.5M | 0.0% | $20.29 | 0 |
| 2025-Q1 | Decreased | 8.4M | -6.9% | $151.6M | 0.0% | $19.93 | 0 |
| 2024-Q4 | Decreased | 9M | -2.9% | $226.8M | 0.0% | $25.12 | 0 |
| 2024-Q3 | Increased | 9.2M | +14.5% | $314.2M | 0.1% | $33.20 | 35 |
| 2024-Q2 | Increased | 8.1M | +5.6% | $298.9M | 0.1% | $37.01 | 33 |